SBD121, a Synbiotic Medical Food for RA Management

NAActive, not recruitingINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

September 30, 2023

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2025

Conditions
Rheumatoid Arthritis
Interventions
OTHER

SBD121

Medical Food

OTHER

Placebo

Placebo

Trial Locations (22)

1336

MHAT Lyulin EAD, Department of Rheumatology, Sofia

1408

Diagnostic Consultative Center XIV - Sofia EOOD, Sofia

2025

Aotearoa Clinical Trials, Auckland

Optimal Clinical Trials, Auckland

2050

Royal Prince Alfred Hospital, Camperdown

2145

Westmead Hospital, Westmead

2150

BJC Health, Parramatta

2170

Liverpool Hospital, Liverpool

2292

Genesis Research Services, Newcastle

2560

Campbelltown Hospital, Campbelltown

2606

Paratus Clinical Canberra, Canberra

3000

Medical Center Tera Medico EOOD, Vrasta

3021

Western Health, St Albans

3065

St. Vincents Hospital Melbourne, Melbourne

3600

Diagnostic Consultative Center 1 - Lom EOOD, Lom

4102

Princess Alexandra Hospital, Woolloongabba

6009

Linear Clinical Trials, Nedlands

6150

Fiona Stanley Hospital, Perth

7011

Southern Clinical Trials, Nelson

7012

Medical Center - Teodora EOOD, Rousse

Unknown

RTL SM SRL/ IMSP Institutul de Cardiologie, Chisinau

Spitalul Clinic Republican Timofei Mosneaga, Chisinau

All Listed Sponsors
lead

Solarea Bio, Inc

INDUSTRY

NCT06005220 - SBD121, a Synbiotic Medical Food for RA Management | Biotech Hunter | Biotech Hunter